Join us for the 13th Annual APA Meeting
September 18-20, 2017

(September 17: Short Course Only)

Omni Providence Hotel 
1 West Exchange Street 
Providence, RI 02903

Speakers from the FDA

Michael Skelly, PhD, Office of Study Integrity and Surveillance, Division of Generic Drug Bioequivalence Evaluation, FDA, “Current Agency Thinking on Immunogenicity Assays and Triggers for Inspections of Immunogenicity Studies Observed During Submission Reviews”

Vernon Toelle, PhD, Center for Veterinary Medicine, FDA, "Modernization of GLP Procedures - Update"

Bowen Cui, PhD, Regulatory Scientific Reviewer at FDA/CDRH/OIR/DMGP, "Development, Validation, and Regulatory Approval of Companion Diagnostics"

APA 2017 Plenary Speakers

F. Peter Guengerich, Tadashi Inagami Chair in Biochemistry, Vanderbilt University School of Medicine

"The Importance of Cytochrome P450 Enzymes in Drug Development"

Henry Fung MD, FACP, FRCPE, Vice-Chair, Department of Hematology/Oncology, Director, Temple-Fox Chase BMT Program

"The Evolving Role of Engineered T-Cells for the Treatment of Cancer"

Hildegund C.J. Ertl, MD, Caspar Wistar Professor in Vaccine Research, Professor, The Wistar Institute Vaccine Center

"Title TBA"

Matthew Stanton, PhD, Vice President, Head of Chemistry, Moderna Therapeutics

"Title TBA"

APA 2017 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Personalized Medicine - Scientific and Regulatory Aspects

Non-Traditional Applications in Bioanalysis / Biotherapeutics

Immuno-Oncology Biomarkers

Controversial Topics in Bioanalysis

Discovery

Qualification/Quantification of Large Molecules

Bioanalytical Issues with Biomarkers

New Technologies

Microbiome

Discovery DMPK Support in a Biotech or Start-Up Company

Mechanistic ADME

Applications of Isotope Labeled Compounds in Drug Development

New Guidance for DDI

Biotransformation Challenges

Biocatalysis for Metabolite Generation and Lead Diversification

Biotransformation of Large Molecules

To Print a Copy of the APA 2016 Program Guide Click Here